9%) NaCl clinical trials

LOW-DOSE DOBUTAMINE INFUSION AND SINGLE-DOSE TOCILIZUMAB IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH HIGH RISK OF CARDIOGENIC SHOCK DEVELOPMENT (DOBERMANN) - A 2X2 MULTIFACTORIAL, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

This study, called DOBERMANN, looks at new ways to help patients who have had a heart attack and are at high risk of a serious complication called cardiogenic shock. It tests two medicines to see if they can improve recovery and reduce risks.